Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-05

Clinical Trial Update: Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion [Phase 3]

View source ↗

Summary

Phase 3 trial assessing SUN-131 Transdermal System versus placebo for chalazion has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUN-131 Transdermal System

Snippet

Sponsor: Senju USA, Inc. | Conditions: Chalazion | Phase 3 | Status: COMPLETED | Results posted: 2021-08-05